Prospera Financial Services Inc trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 25.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,877 shares of the exchange traded fund’s stock after selling 4,087 shares during the period. Prospera Financial Services Inc’s holdings in SPDR S&P Biotech ETF were worth $1,449,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in XBI. Legacy Wealth Managment LLC ID bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000. Ballast Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $36,000. Creative Financial Designs Inc. ADV bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $39,000. Navalign LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $48,000. Finally, Barnes Dennig Private Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $48,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI stock opened at $134.45 on Thursday. SPDR S&P Biotech ETF has a fifty-two week low of $78.06 and a fifty-two week high of $139.19. The firm has a market capitalization of $8.58 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The stock’s 50-day simple moving average is $130.44 and its 200-day simple moving average is $125.67.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
